Probiotics and irritable bowel syndrome

Area of Science:

• Gastroenterology
• Microbiology
• Immunology

Background:

• Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by abdominal pain and altered bowel habits.
• IBS pathogenesis is multifactorial, involving gut motility, visceral hypersensitivity, microbiota, epithelium, immune function, and brain-gut axis.
• Current IBS treatments are often inadequate, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

• To review the existing evidence on the efficacy of probiotics for IBS treatment.
• To elucidate the complex mechanisms through which probiotics exert their effects in IBS.

Main Methods:

• Literature review of studies investigating probiotics in IBS.
• Analysis of research on the biological and physiological effects of probiotics on the gut.

Main Results:

• Growing evidence suggests probiotics are effective in managing IBS symptoms.
• Probiotics offer numerous benefits within the gastrointestinal tract.

Conclusions:

• Probiotics represent a promising therapeutic option for irritable bowel syndrome.
• Further research is needed to fully understand the intricate mechanisms of probiotic action in IBS.